Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block for Chronic Pain After Open Heart Surgery
NCT06315959Completed
- Sponsor
- Ondokuz Mayıs University
- Start
- Apr 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in chronic post-surgical pain (CPSP) (2 arms), sponsored by Ondokuz Mayıs University. Primary endpoint: Chronic pain status at 3 months. Started Apr 2024; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
chronic post-surgical pain (CPSP)
Beyond the preview
Go deeper on NCT06315959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06315959.